In Vivo Treatment with Antibody against IGF-1 Receptor Suppresses Growth of Human Rhabdomyosarcoma and Down-Regulates p34cdc

Thea Kalebic, Lee J. Helman

Research output: Contribution to journalArticlepeer-review

165 Scopus citations

Fingerprint

Dive into the research topics of 'In Vivo Treatment with Antibody against IGF-1 Receptor Suppresses Growth of Human Rhabdomyosarcoma and Down-Regulates p34cdc'. Together they form a unique fingerprint.

Medicine & Life Sciences